Literature DB >> 8263416

Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages.

H F Hoff1, N Zyromski, D Armstrong, J O'Neil.   

Abstract

Aggregation is a characteristic of extensively oxidized (ox-) LDL. We wished to determine whether this structural change contributed even more to the documented poor degradation in macrophages of ox-LDL than the chemical changes. When protein degradation of the soluble and insoluble portions of extensively ox-LDL was compared to that of acetyl LDL in mouse peritoneal macrophages (MPM), we found that the percent of internalized LDL that was degraded was lowest for the insoluble portion (insol. ox-LDL), intermediate for the soluble portion (sol. ox-LDL), and highest for the acetyl LDL, regardless of whether the binding and uptake mechanisms had been excluded, e.g., by performing appropriate pulse-chase studies. As the same order of degradation was found after long-term degradation under cell-free conditions by a mixture of cathepsin B and D, it is likely that poor degradation of ox-LDL by lysosomal proteases is partially responsible for the deficient processing of ox-LDL in MPM. However, when MPM were incubated in a pulse-chase design with LDL that was induced to aggregate by vortexing without oxidizing (vx-LDL), degradation over an 18-h interval of accumulated vx-LDL was almost as low (25%) as that of insol. ox-LDL (18%), in contrast to sol. ox-LDL (60%). Yet, in a cell-free system cathepsin degradation of vx-LDL was as efficient as that of acetyl LDL and LDL. Also, the differences in degradation between sol. and insol. ox-LDL were smaller than in MPM. Thus, it appears that alternative mechanisms to poor proteolysis of substrate were responsible for poor intracellular processing of such aggregated lipoproteins. These results suggest that, although the poorer processing of insol. ox-LDL than sol. ox-LDL may be due, in part, to more deficient proteolytic degradation, particle aggregation per se may play at least as important a role in such deficiencies. This may occur by such mechanisms as altered intracellular trafficking leading to poorer fusion in macrophages of phagosomes containing aggregated lipoproteins with lysosomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263416

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Activation of chaperone-mediated autophagy during oxidative stress.

Authors:  Roberta Kiffin; Christopher Christian; Erwin Knecht; Ana Maria Cuervo
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

2.  Malonyldialdehyde and glyoxal act differently on low-density lipoproteins and endotheliocytes.

Authors:  Elena M Kumskova; Olga A Antonova; Sergey A Balashov; Alla K Tikhaze; Arthur M Melkumyants; Vadim Z Lankin
Journal:  Mol Cell Biochem       Date:  2014-07-27       Impact factor: 3.396

Review 3.  Target acquired: Selective autophagy in cardiometabolic disease.

Authors:  Trent D Evans; Ismail Sergin; Xiangyu Zhang; Babak Razani
Journal:  Sci Signal       Date:  2017-02-28       Impact factor: 8.192

4.  Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages.

Authors:  G Hoppe; J O'Neil; H F Hoff
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL.

Authors:  J A Hamilton; W Jessup; A J Brown; G Whitty
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

6.  Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells.

Authors:  Nadezhda S Sabeva; Christopher M McPhaul; Xiangan Li; Theodore J Cory; David J Feola; Gregory A Graf
Journal:  J Nutr Biochem       Date:  2010-12-15       Impact factor: 6.048

7.  The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-15       Impact factor: 5.555

Review 8.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

Review 9.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.